Plethora Solutions Gets GBP1 Mln Loan For Urology Business
30th Jun 2010 07:48
LONDON (Dow Jones)--Drug company Plethora Solutions Holdings PLC (PLE.LN) Wednesday said it has agreed a GBP1 million, five-year secured term loan from a government fund which will be used to speed the roll-out of its specialty pharmaceutical business. The firm said The Urology Company, which it
Read moreSmall caps round-up: Global Brands, Japan Leisure, Plethora...
5th May 2010 12:52
Shares in Global Brands charged forward as the Domino's Pizza franchise holder in Switzerland reported strong trading in 2010 to follow a good end to 2009. Global says January sales increased 7.4% on January 2009, February sales increased 11.2%, March sales increased 14.5% and April sales increased
Read moreSmall caps round-up: Ark Therapies, Pangea, Shore Capital ...
9th Mar 2010 09:51
Shares in Ark Therapies fell back after the drug developer said it would consider approaches it has received following a recommendation that a further clinical trial would be needed before its brain cancer treatment Cerepro could be approved. Shares in Pangea Diamonds sparkled after the diamond pro
Read moreSmall caps round-up: SDI Group, First Property, Beowulf...
30th Nov 2009 07:37
SDI swung into the black at the half-way stage, although the automated warehousing systems firm said the outlook remains "tough". There was a profit of £305,000 in the six months to 30 September versus a loss of £2.6m in the half year to 31 May 2008 (the year end has now moved from November to Marc
Read moreSmall cap round-up: Entertainment One, Plethora, Goldstone...
23rd Nov 2009 13:17
Film distributor Entertainment One reports record takings for the UK and Canadian opening of The Twilight Saga: New Moon, the sequel to the 2008 box office hit Twilight. New Moon, a film about vampires, has already generated an estimated weekend box office of more than £11m in the UK and $11m in C
Read moreSmall caps round-up: Byotrol, ReNeuron, Accuma...
17th Sep 2009 08:39
Germ-killing product supplier Byotrol said it has seen a significant increase in orders and now expects results for the financial year to September 30 to be ahead of expectations. Shares in Meridian Petroleum gushed higher after the oil and gas firm announced an increase in prospective resources in
Read morePlethora reports PSD502 trial success
29th Jul 2009 08:15
Plethora Solutions has moved closer to global approval for its PSD502 premature ejaculation treatment for men after a final US phase 3 trial met all of its objectives. This study, involving patients from the US, Canada and Europe, was one of two pivotal Phase III studies for PSD502, which were run
Read morePlethora sells rights to key product
26th May 2009 07:57
Drug developer Plethora has sold the rights of its key PSD502 premature ejaculation product to Sciele Pharma to cut its debts and pay back venture capital financing. Under the terms of the agreement, Sciele will make additional upfront payments of $8.4m and also share development costs for PSD502 f
Read more